According to Schering-Plough (nyse: SGP - news - people ) spokeswoman Denise Foy, the label will now report that a rash and a condition called angioedema, a swelling of the hands, feet, lips and throat, were observed in patients who have taken the drug since it was approved.
FORBES: Zetia's Delicate Balance